Article Information
History
- March 24, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michal Kostas1,2,#,
- Ellen Margrethe Haugsten1,2,#,
- Yan Zhen1,2,#,
- Vigdis Sørensen1,2,3,
- Patrycja Szybowska1,2,
- Elisa Fiorito1,2,
- Susanne Lorenz4,
- Gustavo Antonio de Souza5,6,
- Antoni Wiedlocha1,2 and
- Jørgen Wesche1,2,*
- 1Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
- 2Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway
- 3Department of Core Facilities, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
- 4Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, 0379 Oslo, Norway, and the Norwegian Cancer Genomics Consortium, Oslo, Norway
- 5The Brain Institute, Universidade Federal do Rio Grande do Norte, UFRN, Natal, RN 59078, Brazil
- 6Department of Immunology and Centre for Immune Regulation, Oslo University Hospital HF Rikshospitalet, University of Oslo, Oslo, 0424, Norway
- ↵*Author to whom correspondence should be addressed: Jørgen Wesche, Tel: +47 22 78 19 31, Fax: +47 22 78 18 45. Email: jorgen.wesche{at}rr-research.no
↵# These authors contributed equally to this work.